WallStreetZenWallStreetZen

NASDAQ: CTMX
Cytomx Therapeutics Inc Stock Ownership - Who owns Cytomx Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cytomx Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Lloyd A. RowlandGeneral Counsel2025-03-1810,203$0.60
$6.11kSell
Marcia BelvinSVP Chief Scientific Officer2025-03-1819,512$0.60
$11.69kSell
Yuwaye ChuChief Medical Officer2025-03-184,025$0.60
$2.41kSell
Sean A. McCarthyCEO2025-03-1837,656$0.60
$22.56kSell
Christopher OgdenChief Financial Officer2025-03-188,551$0.60
$5.12kSell
Lloyd A. RowlandGeneral Counsel2024-08-204,181$1.23
$5.14kSell
Christopher OgdenChief Financial Officer2024-08-201,984$1.23
$2.44kSell
Marcia BelvinSVP Chief Scientific Officer2024-08-204,181$1.23
$5.14kSell
Jeffrey B. LandauChief Business Officer2024-08-204,181$1.23
$5.14kSell
Sean A. McCarthyCEO2024-08-2013,898$1.23
$17.08kSell

1 of 1

CTMX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CTMX insiders and whales buy or sell their stock.

CTMX Shareholders

What type of owners hold Cytomx Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Tang Capital Management LLC8.33%6,717,825$18.47MInstitution
Bvf Inc6.49%5,228,461$14.38MInstitution
Kevin P. Starr6.45%5,201,767$14.30MInsider
Vanguard Group Inc6.35%5,117,376$14.07MInstitution
Timothy M. 1. Shannon5.66%4,563,247$12.55MInsider
Robert I. Tepper5.40%4,349,864$11.96MInsider
Prosight Management LP4.87%3,930,008$10.81MInstitution
Acadian Asset Management LLC4.01%3,234,035$8.89MInstitution
Millennium Management LLC3.51%2,826,276$7.77MInstitution
Point72 Asset Management LP3.29%2,650,000$7.29MInstitution

1 of 3

CTMX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CTMX56.16%26.79%Net SellingNet Selling
MDWD39.73%0.00%
FENC3.74%96.26%Net SellingNet Selling
TIL6.45%93.55%
DSGN46.26%53.74%Net Selling
View Top Biotech Stocks

Cytomx Therapeutics Stock Ownership FAQ

Who owns Cytomx Therapeutics?

Cytomx Therapeutics (NASDAQ: CTMX) is owned by 56.16% institutional shareholders, 26.79% Cytomx Therapeutics insiders, and 17.06% retail investors. Kevin P. Starr is the largest individual Cytomx Therapeutics shareholder, owning 5.20M shares representing 6.45% of the company. Kevin P. Starr's Cytomx Therapeutics shares are currently valued at $14.30M.

If you're new to stock investing, here's how to buy Cytomx Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.